Skip to main content
Erschienen in: Pädiatrie 5/2016

21.10.2016 | Frühgeburten | Zertifizierte Fortbildung

Neuroprotektion bei Frühgeborenen

Frühe Hirnschäden verhindern

verfasst von: Prof. Dr. med. Richard Berger, Silvio Söder, Harald Abele, Yves Garnier, Ruben Kuon, Werner Rath, Ekkehard Schleussner, Holger Maul

Erschienen in: Pädiatrie | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Frühchen, die vor der 30. Schwangerschaftswoche zur Welt kommen, sind in besonderem Maße von perinatalen Hirnschäden betroffen. Viele dieser Kinder sind schwerbehindert. Dies gilt es zu vermeiden.
Literatur
1.
Zurück zum Zitat Volpe JJ (1995) Neurology of the newborn. WB Saunders, Philadelphia Volpe JJ (1995) Neurology of the newborn. WB Saunders, Philadelphia
2.
Zurück zum Zitat Behl C (2002) Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 3(6):433–442PubMed Behl C (2002) Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 3(6):433–442PubMed
3.
Zurück zum Zitat Dammann O, Leviton A (1997) Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 42(1):1–8CrossRefPubMed Dammann O, Leviton A (1997) Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 42(1):1–8CrossRefPubMed
4.
Zurück zum Zitat Romero R, Savasan ZA, Chaiworapongsa T et al. (2011) Hematologic profile of the fetus with systemic inflammatory response syndrome. J Perinat Med 40(1):19–32PubMedPubMedCentral Romero R, Savasan ZA, Chaiworapongsa T et al. (2011) Hematologic profile of the fetus with systemic inflammatory response syndrome. J Perinat Med 40(1):19–32PubMedPubMedCentral
5.
Zurück zum Zitat Garnier Y, Coumans A, Berger R et al (2001) Endotoxemia severely affects circulation during normoxia and asphyxia in immature fetal sheep. J Soc Gynecol Investig 8(3):134–142CrossRefPubMed Garnier Y, Coumans A, Berger R et al (2001) Endotoxemia severely affects circulation during normoxia and asphyxia in immature fetal sheep. J Soc Gynecol Investig 8(3):134–142CrossRefPubMed
6.
Zurück zum Zitat Garnier Y, Coumans AB, Jensen A et al (2003) Infection-related perinatal brain injury: the pathogenic role of impaired fetal cardiovascular control. J Soc Gynecol Investig 10(8):450–459CrossRefPubMed Garnier Y, Coumans AB, Jensen A et al (2003) Infection-related perinatal brain injury: the pathogenic role of impaired fetal cardiovascular control. J Soc Gynecol Investig 10(8):450–459CrossRefPubMed
7.
Zurück zum Zitat Coumans AB, Middelanis JS, Garnier Y et al (2003) Intracisternal application of endotoxin enhances the susceptibility to subsequent hypoxic-ischemic brain damage in neonatal rats. Pediatr Res 53(5):770–775CrossRefPubMed Coumans AB, Middelanis JS, Garnier Y et al (2003) Intracisternal application of endotoxin enhances the susceptibility to subsequent hypoxic-ischemic brain damage in neonatal rats. Pediatr Res 53(5):770–775CrossRefPubMed
8.
Zurück zum Zitat Feldhaus B, Dietzel ID, Heumann R, Berger R (2004) Effects of interferon-gamma and tumor necrosis factor-alpha on survival and differentiation of oligodendrocyte progenitors. J Soc Gynecol Investig 11(2):89–96CrossRefPubMed Feldhaus B, Dietzel ID, Heumann R, Berger R (2004) Effects of interferon-gamma and tumor necrosis factor-alpha on survival and differentiation of oligodendrocyte progenitors. J Soc Gynecol Investig 11(2):89–96CrossRefPubMed
9.
Zurück zum Zitat Wu YW, Colford JM Jr (2000) Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 284(11):1417–1424CrossRefPubMed Wu YW, Colford JM Jr (2000) Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 284(11):1417–1424CrossRefPubMed
10.
Zurück zum Zitat Shatrov JG, Birch SC, Lam LT et al (2010) Chorioamnionitis and cerebral palsy: a meta-analysis. Obstet Gynecol 116(2 Pt 1):387–392CrossRefPubMed Shatrov JG, Birch SC, Lam LT et al (2010) Chorioamnionitis and cerebral palsy: a meta-analysis. Obstet Gynecol 116(2 Pt 1):387–392CrossRefPubMed
11.
Zurück zum Zitat Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella (2012) Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. Am J Obstet Gynecol 206(5):376–386 Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella (2012) Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. Am J Obstet Gynecol 206(5):376–386
12.
Zurück zum Zitat Elovitz M, Wang Z (2004) Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise. Am J Obstet Gynecol 190(3):693–701CrossRefPubMed Elovitz M, Wang Z (2004) Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise. Am J Obstet Gynecol 190(3):693–701CrossRefPubMed
13.
Zurück zum Zitat Elovitz MA, Mrinalini C (2005) Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation? Am J Obstet Gynecol 193(3 Pt 2):1149–1155CrossRefPubMed Elovitz MA, Mrinalini C (2005) Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation? Am J Obstet Gynecol 193(3 Pt 2):1149–1155CrossRefPubMed
14.
Zurück zum Zitat Quasebarth A (2001) Periventrikulare Leukomalazie und Perinatale Telenzephale Leukoenzephalopathie. Ein und dieselbe Krankheit? Eine neuropathologische Studie anhand von 10 Falldarstellungen. Dissertation, Johann Wolfgang Goethe Universitat Frankfurt am Main Quasebarth A (2001) Periventrikulare Leukomalazie und Perinatale Telenzephale Leukoenzephalopathie. Ein und dieselbe Krankheit? Eine neuropathologische Studie anhand von 10 Falldarstellungen. Dissertation, Johann Wolfgang Goethe Universitat Frankfurt am Main
15.
Zurück zum Zitat American College of Obstetricians and Gynecologists Committee on Obstetric Practice Society for Maternal-Fetal Medicine (2013) Committee Opinion No. 573: magnesium sulfate use in obstetrics. Obstet Gynecol 122(3):727–728 American College of Obstetricians and Gynecologists Committee on Obstetric Practice Society for Maternal-Fetal Medicine (2013) Committee Opinion No. 573: magnesium sulfate use in obstetrics. Obstet Gynecol 122(3):727–728
16.
Zurück zum Zitat Doyle LW, Crowther CA, Middleton P et al (2009) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 1:CD004661PubMed Doyle LW, Crowther CA, Middleton P et al (2009) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 1:CD004661PubMed
17.
Zurück zum Zitat Blauert C, Garnier Y, Berger R (2011) Neuroprotektion durch Magnesium. Ein Uberblick. Geburtsh Frauenheilk 71:79–82CrossRef Blauert C, Garnier Y, Berger R (2011) Neuroprotektion durch Magnesium. Ein Uberblick. Geburtsh Frauenheilk 71:79–82CrossRef
18.
Zurück zum Zitat Rouse DJ, Hirtz DG, Thom E et al (2008) A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 359(9):895–905CrossRefPubMedPubMedCentral Rouse DJ, Hirtz DG, Thom E et al (2008) A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 359(9):895–905CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Conde-Agudelo A, Romero R (2009) Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks’ gestation: a systematic review and metaanalysis. Am J Obstet Gynecol 200(6):595–609CrossRefPubMedPubMedCentral Conde-Agudelo A, Romero R (2009) Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks’ gestation: a systematic review and metaanalysis. Am J Obstet Gynecol 200(6):595–609CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Cahill AG, Caughey AB (2009) Magnesium for neuroprophylaxis: fact or fiction? Am J Obstet Gynecol 200(6):590–594CrossRefPubMed Cahill AG, Caughey AB (2009) Magnesium for neuroprophylaxis: fact or fiction? Am J Obstet Gynecol 200(6):590–594CrossRefPubMed
21.
Zurück zum Zitat Ow LL, Kennedy A, McCarthy EA, Walker SP (2012) Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit. Aust N Z J Obstet Gynaecol 52(4):356–360CrossRefPubMed Ow LL, Kennedy A, McCarthy EA, Walker SP (2012) Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit. Aust N Z J Obstet Gynaecol 52(4):356–360CrossRefPubMed
22.
Zurück zum Zitat Experts for the Prediction and Prevention of Preterm Birth (X4PB) (2013) Pradiktion und Pravention der Fruhgeburt. Frauenarzt 54:1060–1071 Experts for the Prediction and Prevention of Preterm Birth (X4PB) (2013) Pradiktion und Pravention der Fruhgeburt. Frauenarzt 54:1060–1071
23.
Zurück zum Zitat Hofmeyr GJ, Bolton KD, Bowen DC, Govan JJ (1988) Periventricular/intraventricular haemorrhage and umbilical cord clamping. Findings and hypothesis. S Afr Med J 73(2):104–106PubMed Hofmeyr GJ, Bolton KD, Bowen DC, Govan JJ (1988) Periventricular/intraventricular haemorrhage and umbilical cord clamping. Findings and hypothesis. S Afr Med J 73(2):104–106PubMed
24.
Zurück zum Zitat Salmeen KE, Jelin AC, Thiet MP (2014) Perinatal neuroprotection. F1000Prime Rep 6:6. doi:10.12703/P6-6 Salmeen KE, Jelin AC, Thiet MP (2014) Perinatal neuroprotection. F1000Prime Rep 6:6. doi:10.12703/P6-6
25.
Zurück zum Zitat Mercer JS, Vohr BR, McGrath MM et al (2006) Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics 117(4):1235–1242CrossRefPubMedPubMedCentral Mercer JS, Vohr BR, McGrath MM et al (2006) Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics 117(4):1235–1242CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat American College of Obstetricians and Gynecologists (2012) Committee Opinion No.543: timing of umbilical cord clamping after birth. Obstet Gynecol 120(6):1522–1526 American College of Obstetricians and Gynecologists (2012) Committee Opinion No.543: timing of umbilical cord clamping after birth. Obstet Gynecol 120(6):1522–1526
27.
Zurück zum Zitat Rabe H, Jewison A, Alvarez RF et al (2011) Milking compared with delayed cord clamping to increase placental transfusion in preterm neonates: a randomized controlled trial. Obstet Gynecol 117(2 Pt 1):205–211CrossRefPubMed Rabe H, Jewison A, Alvarez RF et al (2011) Milking compared with delayed cord clamping to increase placental transfusion in preterm neonates: a randomized controlled trial. Obstet Gynecol 117(2 Pt 1):205–211CrossRefPubMed
28.
Zurück zum Zitat Berger R, Garnier Y (1999) Pathophysiology of perinatal brain damage. Brain Res Brain Res Rev 30(2):107–134CrossRefPubMed Berger R, Garnier Y (1999) Pathophysiology of perinatal brain damage. Brain Res Brain Res Rev 30(2):107–134CrossRefPubMed
29.
Zurück zum Zitat Bennet L, Roelfsema V, Pathipati P et al (2006) Relationship between evolving epileptiform activity and delayed loss of mitochondrial activity after asphyxia measured by near-infrared spectroscopy in preterm fetal sheep. J Physiol 572(Pt 1):141–154CrossRefPubMedPubMedCentral Bennet L, Roelfsema V, Pathipati P et al (2006) Relationship between evolving epileptiform activity and delayed loss of mitochondrial activity after asphyxia measured by near-infrared spectroscopy in preterm fetal sheep. J Physiol 572(Pt 1):141–154CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Velthoven CT van, Kavelaars A, Heijnen CJ (2012) Mesenchymal stem cells as a treatment for neonatal ischemic brain damage. Pediatr Res 71(4 Pt 2):474–481CrossRefPubMed Velthoven CT van, Kavelaars A, Heijnen CJ (2012) Mesenchymal stem cells as a treatment for neonatal ischemic brain damage. Pediatr Res 71(4 Pt 2):474–481CrossRefPubMed
31.
Zurück zum Zitat Jellema RK, Wolfs TG, Lima Passos V et al (2013) Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemia. PLoS One 8(8):e73031CrossRefPubMedPubMedCentral Jellema RK, Wolfs TG, Lima Passos V et al (2013) Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemia. PLoS One 8(8):e73031CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Lai RC, Arslan F, Lee MM et al (2010) Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4(3):214–222CrossRefPubMed Lai RC, Arslan F, Lee MM et al (2010) Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4(3):214–222CrossRefPubMed
33.
Zurück zum Zitat Trotter A, Bokelmann B, Sorgo W et al (2001) Follow-up examination at the age of 15 months of extremely preterm infants after postnatal estradiol and progesterone replacement. J Clin Endocrinol Metab 86(2):601–603CrossRefPubMed Trotter A, Bokelmann B, Sorgo W et al (2001) Follow-up examination at the age of 15 months of extremely preterm infants after postnatal estradiol and progesterone replacement. J Clin Endocrinol Metab 86(2):601–603CrossRefPubMed
34.
Zurück zum Zitat Muller MM, Middelanis J, Meier C et al (2013) 17β-estradiol protects 7-day old rats from acute brain injury and reduces the number of apoptotic cells. Reprod Sci 20(3):253–261CrossRefPubMed Muller MM, Middelanis J, Meier C et al (2013) 17β-estradiol protects 7-day old rats from acute brain injury and reduces the number of apoptotic cells. Reprod Sci 20(3):253–261CrossRefPubMed
35.
36.
Zurück zum Zitat Deutsch ER, Espinoza TR, Atif F et al (2013) Progesteronef’s role in neuroprotection, a review of the evidence. Brain Res 1530:82–105CrossRefPubMed Deutsch ER, Espinoza TR, Atif F et al (2013) Progesteronef’s role in neuroprotection, a review of the evidence. Brain Res 1530:82–105CrossRefPubMed
Metadaten
Titel
Neuroprotektion bei Frühgeborenen
Frühe Hirnschäden verhindern
verfasst von
Prof. Dr. med. Richard Berger
Silvio Söder
Harald Abele
Yves Garnier
Ruben Kuon
Werner Rath
Ekkehard Schleussner
Holger Maul
Publikationsdatum
21.10.2016
Verlag
Springer Medizin
Erschienen in
Pädiatrie / Ausgabe 5/2016
Print ISSN: 1867-2132
Elektronische ISSN: 2196-6443
DOI
https://doi.org/10.1007/s15014-016-0795-7

Weitere Artikel der Ausgabe 5/2016

Pädiatrie 5/2016 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.